Myeloid Cells in Myocardial Ischemic Injury: The Role of the Macrophage Migration Inhibitory Factor.
inflammation
macrophage migration inhibitory factor
metabolism
myocardial injury
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
05 Aug 2024
05 Aug 2024
Historique:
received:
19
06
2024
revised:
23
07
2024
accepted:
26
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Ischemic heart disease, manifesting as myocardial infarction (MI), remains the leading cause of death in the western world. Both ischemia and reperfusion (I/R) cause myocardial injury and result in cardiac inflammatory responses. This sterile inflammation in the myocardium consists of multiple phases, involving cell death, tissue remodeling, healing, and scar formation, modulated by various cytokines, including the macrophage migration inhibitory factor (MIF). Meanwhile, different immune cells participate in these phases, with myeloid cells acting as first responders. They migrate to the injured myocardium and regulate the initial phase of inflammation. The MIF modulates the acute inflammatory response by affecting the metabolic profile and activity of myeloid cells. This review summarizes the role of the MIF in regulating myeloid cell subsets in MI and I/R injury and discusses emerging evidence of metabolism-directed cellular inflammatory responses. Based on the multifaceted role of the MIF affecting myeloid cells in MI or I/R, the MIF can be a therapeutic target to achieve metabolic balance under pathology and alleviate inflammation in the heart.
Identifiants
pubmed: 39202723
pii: life14080981
doi: 10.3390/life14080981
pmc: PMC11355293
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : BLRD VA
ID : I01 BX005625
Pays : United States
Organisme : NIH HHS
ID : R01HL158515
Pays : United States
Organisme : NIA NIH HHS
ID : R33 AG071249
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL158515
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM149404
Pays : United States
Organisme : CSRD VA
ID : I01 CX002406
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG088199
Pays : United States
Références
Front Immunol. 2018 Nov 01;9:2489
pubmed: 30455688
Cells. 2021 Jul 02;10(7):
pubmed: 34359844
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2180-6
pubmed: 23868943
Expert Opin Ther Targets. 2017 Jul;21(7):671-683
pubmed: 28562118
J Am Coll Cardiol. 2009 Jul 7;54(2):130-8
pubmed: 19573729
J Am Heart Assoc. 2023 Feb 21;12(4):e027600
pubmed: 36789837
Nat Immunol. 2019 Jan;20(1):29-39
pubmed: 30538339
Circulation. 2008 Mar 25;117(12):1594-602
pubmed: 18362243
PeerJ. 2023 Jun 6;11:e15471
pubmed: 37304868
Am Heart J. 2012 Jan;163(1):57-65.e2
pubmed: 22172437
Circulation. 2013 Jul 16;128(3):225-36
pubmed: 23753877
Basic Res Cardiol. 2018 Jun 4;113(4):26
pubmed: 29868933
J Immunol. 2013 Feb 1;190(3):1217-26
pubmed: 23267025
Mediators Inflamm. 2019 Oct 21;2019:7816491
pubmed: 31772506
Nature. 2014 Nov 20;515(7527):431-435
pubmed: 25383517
Metabolism. 2024 Apr;153:155792
pubmed: 38232801
J Clin Invest. 2016 Jun 1;126(6):2151-66
pubmed: 27140396
Circ Res. 2014 Jul 7;115(2):284-95
pubmed: 24786973
Front Cardiovasc Med. 2019 Apr 11;6:42
pubmed: 31032261
Circulation. 2012 Mar 13;125(10):1234-45
pubmed: 22308302
JACC Basic Transl Sci. 2020 Dec 02;5(12):1228-1239
pubmed: 33426378
J Immunol. 2018 Sep 15;201(6):1784-1798
pubmed: 30097529
Redox Biol. 2021 May;41:101946
pubmed: 33823474
Folia Morphol (Warsz). 2006 Feb;65(1):1-5
pubmed: 16783727
Endocr Metab Immune Disord Drug Targets. 2014;14(3):210-7
pubmed: 25051983
PLoS Pathog. 2020 Aug 14;16(8):e1008230
pubmed: 32797076
J Immunol. 2004 Mar 1;172(5):2731-8
pubmed: 14978070
Transl Stroke Res. 2020 Feb;11(1):108-121
pubmed: 30847778
J Exp Med. 2012 Jan 16;209(1):123-37
pubmed: 22213805
J Clin Invest. 2019 Jun 17;129(7):2629-2639
pubmed: 31205028
Int J Mol Sci. 2019 Oct 22;20(20):
pubmed: 31652502
J Immunol. 1998 Oct 15;161(8):4382-7
pubmed: 9780216
Int Immunopharmacol. 2020 Aug;85:106564
pubmed: 32447220
FASEB J. 2015 Nov;29(11):4497-511
pubmed: 26139098
Nat Med. 2007 May;13(5):587-96
pubmed: 17435771
Basic Res Cardiol. 2019 Jul 16;114(5):33
pubmed: 31312919
Circ Res. 2004 Dec 10;95(12):1140-53
pubmed: 15591236
J Clin Invest. 2009 Dec;119(12):3807-16
pubmed: 19920350
Trends Cardiovasc Med. 2012 Jul;22(5):113-7
pubmed: 22902177
Cardiovasc Res. 2019 Jul 1;115(8):1266-1285
pubmed: 30918936
Sci Rep. 2019 Nov 8;9(1):16304
pubmed: 31704966
Circ Res. 2013 Jun 7;112(12):1624-33
pubmed: 23743228
Front Cardiovasc Med. 2019 Mar 18;6:25
pubmed: 30937305
J Am Heart Assoc. 2021 Feb 16;10(4):e019019
pubmed: 33525909
Cell Metab. 2006 Jul;4(1):13-24
pubmed: 16814729
Int J Biol Sci. 2011;7(9):1298-310
pubmed: 22110382
Front Immunol. 2020 Apr 28;11:532
pubmed: 32411122
Immun Inflamm Dis. 2023 Apr;11(4):e840
pubmed: 37102665
J Biol Chem. 1999 Aug 13;274(33):23111-8
pubmed: 10438480
Circulation. 2010 Jul 20;122(3):282-92
pubmed: 20606117
World J Cardiol. 2010 Oct 26;2(10):325-32
pubmed: 21160610
Circ Res. 2019 Jan 18;124(2):263-278
pubmed: 30582448
Arthritis Res Ther. 2019 Jan 7;21(1):9
pubmed: 30616678
Circ Res. 2015 Mar 27;116(7):1182-92
pubmed: 25547404
Sci Rep. 2016 Jul 11;6:29601
pubmed: 27403534
J Mol Cell Cardiol. 2016 Feb;91:123-33
pubmed: 26746143
Aging Cell. 2023 Apr;22(4):e13800
pubmed: 36797808
Science. 1966 Jul 1;153(3731):80-2
pubmed: 5938421
Nat Rev Immunol. 2015 Feb;15(2):117-29
pubmed: 25614321
Front Immunol. 2019 Oct 01;10:2313
pubmed: 31632398
Cardiovasc Res. 2004 Feb 15;61(3):481-97
pubmed: 14962479
Pathol Oncol Res. 2017 Apr;23(2):235-244
pubmed: 27771887
Asian Pac J Cancer Prev. 2012;13(2):607-11
pubmed: 22524832
Cell Rep. 2017 Mar 21;18(12):3005-3017
pubmed: 28329691
Circulation. 2004 Jun 29;109(25):3149-53
pubmed: 15197138
J Mol Cell Cardiol. 2011 Jun;50(6):991-9
pubmed: 21215754
Cell Signal. 2021 Jan;77:109816
pubmed: 33122000
Circ Res. 2012 Jan 6;110(1):159-73
pubmed: 22223212
Circ Res. 2014 May 9;114(10):1611-22
pubmed: 24625784
Proc Natl Acad Sci U S A. 1966 Jul;56(1):72-7
pubmed: 5229858
Nature. 2008 Jan 31;451(7178):578-82
pubmed: 18235500
Sci Rep. 2019 Aug 12;9(1):11599
pubmed: 31406121
J Clin Invest. 2023 Feb 15;133(4):
pubmed: 36480284
Front Immunol. 2018 May 23;9:1132
pubmed: 29875777
Front Immunol. 2023 Jan 19;13:1084460
pubmed: 36741418
Nat Med. 2014 May;20(5):511-7
pubmed: 24784231
Sci Rep. 2018 Apr 30;8(1):6753
pubmed: 29712962
J Am Heart Assoc. 2021 Aug 3;10(15):e020754
pubmed: 34325534
Mediators Inflamm. 2017;2017:7018393
pubmed: 28286377
Cardiovasc Res. 2019 Feb 1;115(2):419-431
pubmed: 30084995
PLoS One. 2013 Oct 01;8(10):e76206
pubmed: 24098445
J Exp Med. 2003 Jun 2;197(11):1467-76
pubmed: 12782713
J Cell Mol Med. 2019 Apr;23(4):2849-2862
pubmed: 30784177
Eur Heart J. 2017 Jan 14;38(3):187-197
pubmed: 28158426
Front Immunol. 2014 Nov 28;5:614
pubmed: 25506346
FASEB J. 2021 May;35(5):e21418
pubmed: 33774873
JACC Basic Transl Sci. 2023 Apr 26;8(7):884-904
pubmed: 37547069
Circulation. 2012 Apr 17;125(15):1880-9
pubmed: 22415145
Cardiovasc Res. 2016 May 1;110(1):51-61
pubmed: 26825554
J Leukoc Biol. 2021 Nov;110(5):893-905
pubmed: 33565160
J Immunol. 2013 Mar 15;190(6):2984-93
pubmed: 23390297
Biomolecules. 2019 Jan 23;9(2):
pubmed: 30678084
J Inflamm (Lond). 2015 Feb 10;12:11
pubmed: 25685072
Transl Res. 2018 Jan;191:15-28
pubmed: 29106912
Antioxid Redox Signal. 2011 Apr 1;14(7):1191-202
pubmed: 20831446
Cardiovasc Res. 2017 Apr 01;113(5):475-487
pubmed: 28339742
J Am Coll Cardiol. 2018 Oct 30;72(18):2213-2230
pubmed: 30360829
Front Cardiovasc Med. 2021 Apr 28;8:647785
pubmed: 33996944
Cells. 2022 Dec 16;11(24):
pubmed: 36552840
Cell Metab. 2018 Sep 4;28(3):463-475.e4
pubmed: 30184486
J Am Coll Cardiol. 2019 Jun 18;73(23):2990-3002
pubmed: 31196457
FASEB J. 2019 Jan;33(1):1401-1414
pubmed: 30130433
Cell. 2016 Oct 6;167(2):457-470.e13
pubmed: 27667687
Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H500-9
pubmed: 25527775